Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-specific Y-encoded protein 3 (TSPY3) is a protein encoded by a gene cluster on the human Y chromosome, specifically expressed in testis germ cells[3][4][5]. It is a chromatin-binding and histone-binding nuclear protein, predicted to be involved in sex differentiation, sperm differentiation, and proliferation of germ cells[3][4][6]. TSPY proteins show sequence similarity to SET and NAP, factors implicated in DNA replication and chromatin regulation[2]. TSPY3 is strongly expressed in subsets of spermatogonia and in early testicular carcinoma in situ, with weaker expression in seminoma tumor cells[2]. TSPY proteins have also been shown to interact with and repress androgen receptor signaling, implicating a potential role in testicular germ-cell tumorigenesis and a possible function as a biomarker for testicular cancer malignancy[1][2]. However, TSPY3 itself is not currently considered a therapeutic drug target, nor are there known interacting drugs or specific safety concerns for therapeutic applications[3][4][1]. Additional notes: - The TSPY gene cluster comprises multiple highly related paralogs, including TSPY1 and TSPY3, with overlapping but not identical sequences[2][3]. While TSPY1 and TSPY are frequently studied regarding cancer/testis antigens and gonadoblastoma, direct clinical or pharmacological studies specifically addressing TSPY3 are lacking. - No specific drugs are documented to target TSPY3. - The aliases often conflate TSPY3 with other cluster members, which may lead to confusion; the entry may represent merged data across paralogs[3]. - Care should be taken to distinguish TSPY3 from TSPY1 and other related proteins when extracting structured data.
Not applicable; no approved drugs or detailed mechanisms for therapeutic targeting reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-specific Y-encoded protein 3 (TSPY3).